Cargando…
Structural basis of peptidomimetic agonism revealed by small-molecule GLP-1R agonists Boc5 and WB4-24
Glucagon-like peptide-1 receptor (GLP-1R) agonists are effective in treating type 2 diabetes and obesity with proven cardiovascular benefits. However, most of these agonists are peptides and require subcutaneous injection except for orally available semaglutide. Boc5 was identified as the first orth...
Autores principales: | Cong, Zhaotong, Zhou, Qingtong, Li, Yang, Chen, Li-Nan, Zhang, Zi-Chen, Liang, Anyi, Liu, Qing, Wu, Xiaoyan, Dai, Antao, Xia, Tian, Wu, Wei, Zhang, Yan, Yang, Dehua, Wang, Ming-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171782/ https://www.ncbi.nlm.nih.gov/pubmed/35561211 http://dx.doi.org/10.1073/pnas.2200155119 |
Ejemplares similares
-
Structural analysis of the dual agonism at GLP-1R and GCGR
por: Li, Yang, et al.
Publicado: (2023) -
Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors
por: Zhao, Fenghui, et al.
Publicado: (2022) -
A potentially serious adverse effect of GLP-1 receptor agonists
por: Lu, Jinmiao, et al.
Publicado: (2023) -
GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist–Induced Nausea and Emesis in Preclinical Models
por: Borner, Tito, et al.
Publicado: (2021) -
BocODD1 and BocODD2 Regulate the Biosynthesis of Progoitrin Glucosinolate in Chinese Kale
por: Wu, Shuanghua, et al.
Publicado: (2022)